RESPONSE OF CHILDHOOD RHABDOMYOSARCOMA TO COMBINATION CHEMOTHERAPY

被引:59
作者
PRATT, CB
机构
[1] St. Jude Children's Research Hospital, Memphis, TN
[2] University of TennesseeMedical Units, Memphis, TN
关键词
D O I
10.1016/S0022-3476(69)80145-9
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Seven patients with far advanced rhabdomyosarcomawere treated with combination chemotherapy consisting of vincristine, dactinomycin, and cyclophosphamide. One patient with bone marrow involvement had a complete response lasting 7.5 months. Partial responses were obtained in 6 patients. The responses of these patients indicate that this combination of agents may be a valuable adjunct to surgery and/or radiotherapy in treating localized or regional disease. A classification for the clinical staging of rhabdomyosrcoma is presented. © 1969 The C. V. Mosby Company.
引用
收藏
页码:791 / &
相关论文
共 10 条
[1]   EMBRYONAL RHABDOMYOSARCOMA - 5 YEAR SURVIVAL OF A PATIENT TREATED BY RADIATION AND CHEMOTHERAPY [J].
EDLAND, RW .
AMERICAN JOURNAL OF ROENTGENOLOGY RADIUM THERAPY AND NUCLEAR MEDICINE, 1967, 99 (02) :400-+
[2]   CYCLOPHOSPHAMIDE TREATMENT FOR METASTATIC SOFT TISSUE SARCOMA - INTERMITTENT LARGE DOSES IN TREATMENT OF CHILDREN [J].
HADDY, TB ;
NORA, AH ;
SUTOW, WW ;
VIETTI, TJ .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1967, 114 (03) :301-&
[3]   CHILDHOOD MALIGNANT TUMORS - CONCURRENT CHEMOTHERAPY WITH DACTINOMYCIN AND VINCRISTINE SULFATE [J].
JAMES, DH ;
HUSTU, O ;
WRENN, EL ;
JOHNSON, WW .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1966, 197 (12) :1043-&
[4]  
MEADOWS D, 1966, SOUTHERN MED J, V59, P1475
[5]  
NELSON AJ, 1968, CANCER-AM CANCER SOC, V22, P64, DOI 10.1002/1097-0142(196807)22:1<64::AID-CNCR2820220110>3.0.CO
[6]  
2-V
[7]   RHABDOMYOSARCOMA IN CHILDREN [J].
PINKEL, D ;
PICKREN, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1961, 175 (04) :293-&
[8]  
PRATT CB, 1968, CANCER CHEMOTH REP, V52, P489
[9]  
SITARZ ANNELIESE L., 1965, CANCER CHEMOTHERAP REP, V45, P45
[10]  
SUTOW WW, 1968, PEDIATRICS, V38, P465